Ritholtz Wealth Management’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q4 | – | Sell |
-2,122
| Closed | -$219K | – | 779 |
|
2023
Q3 | $219K | Buy |
2,122
+452
| +27% | +$46.7K | 0.01% | 635 |
|
2023
Q2 | $203K | Buy |
1,670
+145
| +10% | +$17.6K | 0.01% | 619 |
|
2023
Q1 | $234K | Sell |
1,525
-713
| -32% | -$109K | 0.01% | 579 |
|
2022
Q4 | $402K | Sell |
2,238
-1,069
| -32% | -$192K | 0.02% | 404 |
|
2022
Q3 | $391K | Buy |
+3,307
| New | +$391K | 0.02% | 464 |
|
2022
Q2 | – | Sell |
-1,350
| Closed | -$233K | – | 578 |
|
2022
Q1 | $233K | Buy |
1,350
+15
| +1% | +$2.59K | 0.02% | 471 |
|
2021
Q4 | $339K | Sell |
1,335
-61
| -4% | -$15.5K | 0.02% | 383 |
|
2021
Q3 | $537K | Buy |
+1,396
| New | +$537K | 0.04% | 255 |
|